Anti-Gentamicin antibody [EPR27991-65]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Gentamicin antibody [EPR27991-65] (AB314126)
Immunohistochemical analysis of paraffin-embedded Human cerebrum tissue labeling Gentamicin with ab314126 at 1/500 (1.018 µg/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Negative control : No staining on human cerebrum. The section was incubated with ab314126 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IP
Supplier Data
Immunoprecipitation - Anti-Gentamicin antibody [EPR27991-65] (AB314126)
Gentamicin was immunoprecipitated from 0.35 mg RAW264.7 treated with 0.5mg/mL Gentamicin-crosslink-BSA for 4 hours whole cell lysate with ab314126 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab314126 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : RAW264.7 treated with 0.5mg/mL Gentamicin-crosslink-BSA for 4 hours whole cell lysate Lane 2 : ab314126 IP in RAW264.7 treated with 0.5mg/mL Gentamicin-crosslink-BSA for 4 hours whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab314126 in RAW264.7 treated with 0.5 mg/mL Gentamicin-crosslink-BSA for 4 hours whole cell lysate. Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 3 seconds
All lanes:
Immunoprecipitation - Anti-Gentamicin antibody [EPR27991-65] (ab314126) at 1/30 dilution
All lanes:
RAW264.7 treated with 0.5mg/mL Gentamicin-crosslink-BSA for 4 hours whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 3s
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-Gentamicin antibody [EPR27991-65] (AB314126)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized Isotype (Left) / RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 0.5 mg/ml Gentamicin-crosslink-BSA-FITC for 4 hours for 4h (Middle) / RAW 264.7 treated with 0.5 mg/ml crosslink-BSA-FITC for 4h (Right) cells labelling Gentamicin with ab314126 at 1/500 dilution (0.1 ug)/ Middle and Right compared with a Rabbit monoclonal IgG (ab172730) / Left isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Gentamicin antibody [EPR27991-65] (AB314126)
Immunohistochemical analysis of paraffin-embedded RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) labeling Gentamicin with ab314126 at 1/500 (1.018 µg/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Panel A. Positive staining on RAW 264.7 treated with 0.5 mg/mL Gentamicin-crosslink-BSA-FITC for 4h; Panel B. Negligible staining on untreated RAW 264.7. The section was incubated with ab314126 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Gentamicin antibody [EPR27991-65] (AB314126)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) cells labelling Gentamicin with ab314126 at 1/100 (5.09 µg/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2 µg/ml) dilution (Red). Confocal image showing positive staining in RAW 264.7 cells treated with 0.5mg/mL Gentamicin-crosslink-BSA-FITC for 4 hours, and no staining when 0.5 mg/mL crosslink-BSA-FITC was incubated for 4 hours. Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 (2 µg/ml) dilution.
- WB
Supplier Data
Western blot - Anti-Gentamicin antibody [EPR27991-65] (AB314126)
Blocking and diluting buffer and concentration : 5% NFDM/TBST In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution. In Western blot, Anti-Bovine Serum Albumin antibody [EPR12774] (ab192603) staining at 1/1000 dilution. Exposure time : 3 seconds
All lanes:
Western blot - Anti-Gentamicin antibody [EPR27991-65] (ab314126) at 1/1000 dilution
Lane 1:
Untreated RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 2:
RAW264.7 treated with 0.5mg/mL Gentamicin-crosslink-BSA for 4 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 3s
- Dot
Supplier Data
Dot Blot - Anti-Gentamicin antibody [EPR27991-65] (AB314126)
Dot blot analysis of Gentamicin using ab314126 at 1 : 1000 (0.509 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution. Exposure time : 180 seconds. Blocking and diluting buffer and concentration : 5% NFDM/TBST
- cELISA
Supplier Data
Competitive ELISA - Anti-Gentamicin antibody [EPR27991-65] (AB314126)
Indirect ELISA analysis of ab314126 at 20 ng/ml. The Secondary antibody used was Streptavidin-Horseradish Peroxidase at 1 : 20000 dilution. Antigen : Gentamicin. Antigen concentration : 0-25 ng/ml
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The main activity of this antibiotic disrupts the normal function of the bacterial ribosome. It is not a part of a complex but interacts with the ribosome complex consisting of ribosomal RNA and various ribosomal proteins. By binding to the 30S subunit gentamicin causes errors in the translation process preventing the bacteria from synthesizing necessary proteins needed for growth and proliferation.
Pathways
Disruptions caused by gentamicin impact the bacterial translation pathway significantly. It affects the elongation cycle of protein synthesis where aminoacyl-tRNA enters the ribosomal A site. The faulty incorporation of amino acids due to gentamicin's effect hinders the elongation pathway leading to nonfunctional proteins and bacterial death. This process relates components like other aminoglycoside antibiotics such as amikacin which function similarly.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com